Introduction {#s1}
============

Obesity is a significant risk factor for a vast number of diseases, such as cardiovascular disease, type 2 diabetes, hypertension, fatty liver disease, and numerous cancers ([@B1],[@B2]). Obesity results from increased energy intake or defects in energy expenditure. The excessive energy is stored as triglycerides in the white adipose tissue (WAT). A second type of adipose tissue, known as brown adipose tissue (BAT), has been well known for a long time in rodents and newborn humans ([@B3]). BAT is specialized for energy expenditure, a process called adaptive thermogenesis, which is a physiological mechanism during which energy is dissipated to generate heat in response to cold temperatures and possibly diet ([@B3],[@B4]). The very densely packed mitochondria in BAT produce heat through a unique protein called uncoupling protein-1 (UCP1). UCP1 uncouples mitochondrial oxidative phosphorylation from ATP production and dissipates chemical energy as heat, thereby strongly increasing energy expenditure ([@B5]). Peroxisome proliferator--activated receptor γ (PPARγ) coactivator 1α (PGC1α) promotes BAT-mediated thermogenesis by directly regulating the expression of *Ucp1*. Because of their critical role in thermogenesis, PGC1α and UCP1 expression and activity are tightly controlled by several other factors that either positively or negatively regulate PGC1α and UCP1. Some of the important factors that positively regulate PGC1α or UCP1 are FOXC2, SRC1, CREB, IRF4, SIRT3, and p38 MAPK, whereas RIP140, LXRα, Cidea, pRB, SRC2, Twist-1, and TRPV4 negatively regulate PGC1α and/or UCP1 ([@B4],[@B6]--[@B9]).

In addition to WAT and BAT, a third type of adipocytes arises in the body in response to certain physiological stimuli. For example, in response to cold and β-androgen receptor or PPARγ agonists, pools of UCP1-expressing brown-like adipocytes are detected in mouse WAT ([@B10],[@B11]). These adipocytes are called beige or brite cells. Beige and brown adipocytes share a number of thermogenic genes, such as *Pgc1a*, *Ucp1*, *Cidea*, and *Prdm16*; however, beige cells also express several unique genes such as *CD40*, *CD137*, *Tmem26*, and *Tbx1* that apparently reflect their distinct developmental origin ([@B12]). Lineage-tracing studies revealed that the beige adipocytes are derived from adipose progenitor/precursor cells ([@B13]). In these cells, early B-cell factor-2 (Ebf2) and PPARγ cooperatively induce the expression of *Prdm16*, which determines the beige adipocyte cell fate ([@B14]--[@B16]). PRDM16 can bind to and promote the transcriptional activity of numerous factors, such as PPARα, PPARγ, and PGC1α, thus functioning as a critical activator of brown/beige adipocyte cell fate ([@B15],[@B17]). Induced expression of *Prdm16* or *Ebf2* is sufficient to convert white adipose precursors into brown-like UCP1-expressing cells in vitro ([@B14],[@B17]). Similarly, forced expression of *Ebf2* or *Prdm16* stimulates beige cell formation in subcutaneous WAT, and transgenic mice display increased energy expenditure and reduced weight gain in response to a high-fat diet (HFD) ([@B18],[@B19]).

Inhibitor of differentiation 1 (Id1) is a helix-loop-helix transcription factor that lacks a DNA binding domain (DBD). Id1 directly binds to other transcription factors and suppresses their transcriptional activity, thereby playing an important role in a number of cellular processes, such as cell proliferation, differentiation, hematopoiesis, and cancer cell metabolic adaptation ([@B20]--[@B22]). However, the adipose tissue--specific function of Id1 and its relative contribution to body energy expenditure remains unclear. Moreover, although Id1 is expressed in both BAT and WAT, the specific involvement of Id1 in BAT-mediated thermogenesis or browning of WAT has not been fully established. To understand the adipose tissue--specific function of Id1, we have generated adipose tissue--specific *Id1* transgenic mice (*aP2-Id1^Tg+^*). We discovered that adipose-specific overexpression of Id1 causes age- and HFD-associated obesity in male mice, whereas female mice are resistant to Id1-induced obesity. At the molecular level, Id1 directly binds to the central regulators of BAT thermogenesis and WAT browning, PGC1α, and Ebf2 ([@B4],[@B16],[@B19]) and suppresses their transcriptional activity. The results highlight a novel function of Id1 in BAT thermogenesis and WAT browning and, thus, in body energy homeostasis.

Research Design and Methods {#s2}
===========================

Mice and Diet {#s3}
-------------

The *aP2-Id1^Tg+^* transgenic expression vector and mice were generated by using the services of Cyagen Biosciences (Santa Clara, CA). Of four transgenic lines generated, one line showed strong expression of Id1 in WAT and BAT and was used for this study. The following primers were used to distinguish the *aP2-Id1^Tg+^* transgenic from control *aP2-Id1^Tg−^* mice: Tg F: ATCTTTAAAAGCGAGTTCCCT; Tg R: CTCCGACAGACCAAGTACCA; internal control F: ACTCCAAGGCCACTTATCACC; and internal control R: ATTGTTACCAACTGGGACGACA. Endogenous mouse β-actin was used as the internal control. C57BL/6J background *aP2-Id1^Tg+^*, *aP2-Id1^Tg−^*, *Id1^+/+^*, and *Id1^−/−^* mice were used for this study. Mice were housed in a barrier facility under standard conditions with a 12-h light-dark cycle. Mice were handled in compliance with National Institutes of Health guidelines for animal care and use. All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Augusta University (Augusta, GA). Mice were fed a standard chow normal diet (ND) containing 6% crude fat (Harlan Teklad Rodent Diet 2918). For the HFD experiments, 1-month-old mice were switched from ND to HFD (60% kcal from fat, D12492; Research Diets, New Brunswick, NJ) and fed for 12 weeks. For cold exposure studies, mice were housed in standard cages without bedding, and the cages were placed in the cold room (4°C) for 4--12 h. Mice were then euthanized and tissues harvested.

Quantitative Real-Time PCR {#s4}
--------------------------

Total RNA from cells and tissues was prepared by using TRIzol Reagent (15596-026; Life Technologies) according to the manufacturer's instructions. Total RNA (2 μg) from each sample was reverse transcribed into cDNA by using a RevertAid Reverse Transcription Kit (K1691; Thermo Fisher Scientific) according to the manufacturer's instructions. Quantitative PCR (qPCR) analysis was performed by using Power SYBR Green PCR Master Mix (4367659; Applied Biosystems) according to the manufacturer's instructions in a 20-μL final reaction volume in 96-well plates (4346907; Applied Biosystems). The qPCR primers used are listed in [Supplementary Table 1](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1).

Statistical Analysis {#s5}
--------------------

The quantitative data for the experiments are presented as mean ± SD. Statistical analyses were performed by unpaired Student *t* test, and *P* \< 0.05 was considered statistically significant. Oxymax metabolic data were analyzed by one-way repeated-measures ANOVA, and *P* \< 0.01 was considered statistically significant. Detailed methods are provided in the [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1).

Results {#s6}
=======

Id1 Is Expressed in Adipose Tissues, and Its Expression Is Strongly Induced During Brown Adipocyte Differentiation {#s7}
------------------------------------------------------------------------------------------------------------------

To investigate whether Id1 plays a role in adipose tissue metabolism, we analyzed the expression pattern of Id1 protein in mouse BAT, inguinal WAT (iWAT), epididymal WAT (eWAT), and retroperitoneal WAT (rWAT). Id1 was expressed in all the adipose tissues, and its expression was relatively stronger in BAT than in iWAT, eWAT, and rWAT ([Fig. 1*A* and *B*](#F1){ref-type="fig"}). In addition, analysis of Id1 mRNA revealed a relatively higher Id1 mRNA in BAT and eWAT than in iWAT and rWAT ([Fig. 1*C*](#F1){ref-type="fig"}). To investigate whether Id1 is required for brown adipocyte differentiation, we induced differentiation in the HIB1B brown preadipocyte cell line and detected a threefold induction of *Id1* mRNA in day 4 differentiated cells compared with undifferentiated cells ([Fig. 1*D* and *E*](#F1){ref-type="fig"}). The adipocyte differentiation marker aP2 and the brown adipocyte--specific thermogenic genes *Pgc1α* and *Ucp1* also were induced in day 4 differentiated cells, as expected ([Fig. 1*E*](#F1){ref-type="fig"}). Further analysis at the protein level revealed low levels of Id1 in undifferentiated HIB1B cells, and its expression was steadily elevated during the differentiation process ([Fig. 1*F*](#F1){ref-type="fig"}). To further confirm that Id1 expression is induced in differentiated cells compared with nondifferentiated HIB1B cells, we performed Id1/aP2 costaining, which revealed increased Id1 staining in aP2-positive cells ([Fig. 1*G*](#F1){ref-type="fig"}). These observations suggest that Id1 plays a role in brown adipocyte differentiation or in brown adipocyte--associated thermogenesis.

![Id1 expression is induced during brown adipocyte differentiation in HIB1B cells. *A* and *B*: Expression levels of Id1 and β-actin in various adipose tissues of 2-month-old C57BL/6J mice (*A*). After acquiring images, band intensities were measured and normalized to β-actin by the Li-Cor Odyssey system (*B*). *C*: Id1 mRNA transcript levels in various adipose tissues of 2-month-old C57BL/6J mice. Compared with BAT or eWAT, Id1 expression level is lower in iWAT and rWAT (*n* = 3). *D*: Oil Red O staining of nondifferentiated (day 0) and day 6 and day 8 differentiated HIB1B brown preadipocyte cells. *E*: Id1, aP2, PGC1α, and Ucp1 mRNA transcript levels in day 4 differentiated (D) HIB1B cells compared with nondifferentiated (ND) cells (*n* = 3). *F*: The expression patterns of Id1, PPARγ, PGC1α, UCP1, aP2, and β-actin during HIB1B brown adipocyte differentiation at the indicated time points. *G*: Immunofluorescence costaining of aP2 and Id1 on day 4 differentiated HIB1B cells showing strong expression of Id1 in aP2-positive cells. Original magnification ×20. *H*: Relative mRNA transcript levels of indicated genes in control and Id1-OE nondifferentiated HIB1B cells (*n* = 3). *I*: FACS analysis of unstained and nonyl acridine orange--stained control and Id1-OE nondifferentiated HIB1B cells. *J*: The relative fluorescence level (FL) of nonyl acridine orange in control and Id1-OE cells (*n* = 3). *K*: VO~2~ rate of control and Id1-OE nondifferentiated HIB1B cells (*n* = 4). Data are mean ± SD. \**P* \< 0.05; \*\**P* \< 0.005; \*\*\**P* \< 0.0005.](db161079f1){#F1}

Id1 Is Not Required for Brown Adipocyte Differentiation {#s8}
-------------------------------------------------------

Strong induction of Id1 during brown adipocyte differentiation prompted us to ask whether Id1 promotes brown adipocyte differentiation. Id1 expression was strongly induced in differentiated HIB1B cells, whereas its expression was low in undifferentiated cells ([Fig. 1*F*](#F1){ref-type="fig"}); therefore, we asked whether forced expression of Id1 in undifferentiated HIB1B cells accelerates differentiation. To this end, we generated an Id1-overexpressed (Id1-OE) HIB1B cell line ([Supplementary Fig. 1*A*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1)). Analysis of the expression levels of various mitochondrial and thermogenesis genes in nondifferentiated control and Id1-OE HIB1B cells revealed downregulation of *Pgc1α*, *Ucp1*, *Cox4*, *Cpt1b*, *Dio2*, and *ERRα* in Id1-OE compared with control HIB1B cells ([Fig. 1*H*](#F1){ref-type="fig"}). In addition, mitochondrial content was reduced in Id1-OE cells compared with control cells ([Fig. 1*I* and *J*](#F1){ref-type="fig"}). Consequently, Id1-OE cells displayed reduced respiration (VO~2~) compared with control nondifferentiated HIB1B cells ([Fig. 1*K*](#F1){ref-type="fig"}). These results indicate that Id1 suppresses mitochondrial and thermogenesis genes and, thus, that Id1 could play a role in brown adipocyte differentiation. However, induction of brown adipogenesis in the control and Id1-OE HIB1B cells showed no significant difference as revealed by Oil Red O staining and the expression levels of the adipocyte differentiation marker aP2 and brown adipocyte markers PGC1α and Ucp1 in fully differentiated adipocytes ([Supplementary Fig. 1*B* and *C*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1)). To investigate whether loss of Id1 has any effect on brown adipocyte differentiation, we knocked down Id1 in HIB1B cells by short hairpin RNA ([Supplementary Fig. 1*D*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1)) and induced brown adipocyte differentiation. We did not observe significant differences in the differentiation between control and Id1 short hairpin RNA HIB1B cells as revealed by Oil Red O staining and the expression levels of aP2, PGC1α, and Ucp1 in fully differentiated adipocytes ([Supplementary Fig. 1*E* and *F*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1)). Together, these results suggest that Id1 is not required for brown adipocyte differentiation and that Id1 might have a different function in brown adipocytes.

Reduced Energy Expenditure and Increased Adiposity in *aP2-Id1^Tg+^* Mice {#s9}
-------------------------------------------------------------------------

Previously, *aP2* promoter--driven transgenic mice have been extensively used to study BAT thermogenesis and WAT browning ([@B15],[@B19],[@B23]). Therefore, to investigate the specific function of Id1 in BAT-mediated thermogenesis and adipose tissue metabolism in a more physiologically relevant in vivo system, we generated *aP2-Id1^Tg+^* transgenic mice where Id1 is specifically overexpressed in adipose tissues ([Fig. 2*A*--*C*](#F2){ref-type="fig"}). We found that Id1 expression is three- to fourfold higher in the adipose tissues of *aP2-Id1^Tg+^* compared with *aP2-Id1^Tg−^* control mice ([Fig. 2*C*](#F2){ref-type="fig"}). To investigate whether adipose-specific overexpression of Id1 causes metabolic alterations that lead to changes in body adiposity, we measured body weight and fat mass in *aP2-Id1^Tg+^* and control mice fed an ND. The male *aP2-Id1^Tg+^* mice steadily gained more body weight, and the body weight and fat mass were significantly increased in 6-month-old adult *aP2-Id1^Tg+^* males compared with *aP2-Id1^Tg−^* males ([Fig. 2*D* and *E*](#F2){ref-type="fig"}), whereas lean mass, bone mass, and interscapular BAT weight were unchanged between the two genotypes ([Supplementary Fig. 2*A*--*E*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1)). In contrast, females did not show differences in body weight and fat mass between the two genotypes in 2-month-old (young) and 6-month-old (adult) mice ([Fig. 2*F* and *G*](#F2){ref-type="fig"}). These observations suggest that females are resistant to Id1-induced weight gain, whereas *aP2-Id1^Tg+^* male mice accumulate more fat mass over time. To investigate whether increased fat mass and weight gain in *aP2-Id1^Tg+^* mice are due to changes in metabolic activity, we measured various metabolic parameters in 2- and 6-month-old mice by indirect open-circuit calorimeter (Oxymax/Comprehensive Lab Animal Monitoring System \[CLAMS\]), and detected reduced VO~2~, VCO~2~, and heat production (thermogenesis) in *aP2-Id1^Tg+^* compared with *aP2-Id1^Tg−^* mice ([Fig. 2*H*](#F2){ref-type="fig"} and [Supplementary Fig. 3*A*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1)), indicating that body energy expenditure is reduced in *aP2-Id1^Tg+^* male mice. Physical activity and food consumption were unchanged between the two genotypes ([Fig. 2*I* and *J*](#F2){ref-type="fig"} and [Supplementary Fig. 3*B* and *C*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1)), further confirming that reduced energy expenditure is mainly responsible for increased body weight and fat mass gain in *aP2-Id1^Tg+^* male mice. Consequently, we observed increased lipid accumulation in the BAT and white adipocyte hypertrophy in 6-month-old *aP2-Id1^Tg+^* compared with *aP2-Id1^Tg−^* mice ([Fig. 2*K*--*M*](#F2){ref-type="fig"}). These observations suggest that adipose tissue--specific overexpression of Id1 suppresses body energy expenditure and promotes weight gain in male mice.

![Adipose tissue--specific overexpression of Id1 reduces energy expenditure. *A*: The *aP2-Id1* expression vector used to generate adipose tissue--specific *aP2-Id1^Tg+^* transgenic mice. f1 ori, f1 single-strand RNA origin; pUC ori, pUC origin; TB, transcription blocker. *B*: Gel photograph showing the PCR bands of internal control (IC) (β-actin) and Id1 transgene. *C*: Expression levels of Id1 protein and β-actin in the eWAT and BAT of *aP2-Id1^Tg−^* control and *aP2-Id1^Tg+^* mice. *D*: Body weight of male *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* mice (*n* = 8--10) at the indicated time points. *E*: Fat mass density in 2- and 6-month-old *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice measured by multislice computed tomography scanner (*n* = 5--6). *F*: Body weight of female *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* mice (*n* = 8--10) at the indicated time points. *G*: Fat mass density in 2- and 6-month-old *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* female mice measured by multislice computed tomography scanner (*n* = 5). Data are mean ± SD. *H*--*J*: VO~2~ rate, VCO~2~, and heat production (*H*); food consumption (*I*); and physical activity (*J*) in *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice measured for 4 days with Oxymax/CLAMS (*n* = 5--6). *K*: Representative hematoxylin-eosin--stained BAT and eWAT sections. Scale bars = 10 μm. *L* and *M*: Adipocyte size distribution (*L*) and the average size of adipocytes (*M*) in the eWAT of 6-month-old *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice. Data are mean ± SD. \**P* \< 0.05. bp, base pair; M, month; n.s, not significant.](db161079f2){#F2}

*aP2-Id1^Tg+^* Male Mice Are Prone to HFD-Induced Obesity {#s10}
---------------------------------------------------------

On an ND (6% kcal from fat), *aP2-Id1^Tg+^* male mice gained more body weight over time and displayed reduced energy expenditure ([Fig. 2*D*, *E*, and *H*](#F2){ref-type="fig"}). Therefore, we asked whether *aP2-Id1^Tg+^* mice are prone to HFD-induced obesity. In response to 12 weeks of HFD (60% kcal from fat), *aP2-Id1^Tg+^* mice gained more body weight than *aP2-Id1^Tg−^* mice ([Fig. 3*A* and *B*](#F3){ref-type="fig"}). The *aP2-Id1^Tg+^* mice showed an increased amount of visceral fat ([Fig. 3*C*](#F3){ref-type="fig"}), larger eWAT pads ([Fig. 3*D* and *E*](#F3){ref-type="fig"}), increased accumulation of body fat ([Fig. 3*F*](#F3){ref-type="fig"}), and higher blood glucose, insulin, and leptin levels ([Supplementary Table 2](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1)) than *aP2-Id1^Tg−^* mice. Consequently, *aP2-Id1^Tg+^* male mice displayed increased accumulation of lipids in and around the interscapular BAT ([Fig. 3*G*](#F3){ref-type="fig"}) and increased liver size and weight compared with *aP2-Id1^Tg−^* mice ([Fig. 3*H* and *I*](#F3){ref-type="fig"}). Histological analysis of WAT from *aP2-Id1^Tg+^* mice showed white adipocyte hypertrophy ([Fig. 3*J*--*L*](#F3){ref-type="fig"}) and increased lipid accumulation in the BAT and liver compared with *aP2-Id1^Tg−^* mice ([Fig. 3*M* and *N*](#F3){ref-type="fig"}). To investigate whether increased weight gain in *aP2-Id1^Tg+^* mice in response to HFD is due to changes in metabolic activity, we measured various metabolic parameters. Food consumption and physical activity were unchanged between the two genotypes ([Fig. 3*O* and *P*](#F3){ref-type="fig"}), but reduced VO~2~, VCO~2~, and thermogenesis in *aP2-Id1^Tg+^* compared with *aP2-Id1^Tg−^* mice were detected ([Fig. 3*Q*--*S*](#F3){ref-type="fig"}). Moreover, thermogenic and mitochondrial gene expression was reduced in the BAT of HFD-fed *aP2-Id1^Tg+^* compared with *aP2-Id1^Tg−^* mice ([Supplementary Fig. 3*D* and *E*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1079/-/DC1)). In contrast to males, *aP2-Id1^Tg+^* females did not gain significant body weight compared with *aP2-Id1^Tg−^* controls in response to HFD (data not shown). Together, these results indicate that *aP2-Id1^Tg+^* male mice are prone to HFD-induced obesity as a result of reduced energy expenditure.

![*aP2-Id1^Tg+^* mice are prone to HFD-induced obesity. *A*: Body weights of HFD-fed male *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* mice (*n* = 9) at the indicated time points. *B*--*D*: Representative photographs of *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice (*B*), visceral fat (*C*), and eWAT pads (*D*) after 12 weeks of HFD. *E*: Average weight of eWAT pads in *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* mice (*n* = 6). *F*: Fat mass density in *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice after 12 weeks of HFD measured by multislice computed tomography scanner (*n* = 6). *G* and *H*: Representative photographs of interscapular BAT (*G*) and liver (*H*) of *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice. BAT weight is significantly higher in HFD-fed *aP2-Id1^Tg+^* mice than in *aP2-Id1^Tg−^* mice as a result of higher lipid accumulation (*n* = 6). *I*: Average liver weight in *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* mice after 12 weeks of HFD (*n* = 6). *J*--*L*: Representative hematoxylin-eosin--stained eWAT sections (*J*), adipocyte size distribution (*K*), and the average size of adipocytes (*L*) in the eWAT of HFD-fed *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice (*n* = 6). *M* and *N*: Representative hematoxylin-eosin--stained BAT and liver sections of HFD-fed *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice. *O*--*S*: Food consumption (*O*), physical activity (*P*), VO~2~ rate (*Q*), VCO~2~ (*R*), and heat production (*S*) in HFD-fed (12 weeks) *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice measured for 4 days by using Oxymax/CLAMS (*n* = 5). Data are mean ± SD. Scale bars = 10 μm. \**P* \< 0.05. n.s, not significant.](db161079f3){#F3}

Id1 Suppresses BAT Thermogenesis by Inhibiting PGC1α Transcriptional Activity {#s11}
-----------------------------------------------------------------------------

To investigate how Id1 is expressed in vivo in response to thermogenic stimuli such as cold exposure or HFD, we exposed wild-type mice to 4°C for 4 h, which led to a strong induction of Id1 in BAT ([Fig. 4*A*](#F4){ref-type="fig"}). Similarly, 1 week of HFD feeding led to strong induction of Id1 in the BAT of wild-type mice ([Fig. 4*B*](#F4){ref-type="fig"}), indicating that Id1 is involved in BAT thermogenesis. Therefore, we asked whether reduced energy expenditure in *aP2-Id1^Tg+^* mice is due to downregulation of thermogenesis genes in BAT. At room temperature (RT) (23°C), we detected some reduction in the expression of *Ucp1* in the BAT of *aP2-Id1^Tg+^* mice, but it did not reach statistical significance. *Elovl3*, on the other hand, was significantly downregulated compared with *aP2-Id1^Tg−^* BAT ([Fig. 4*C* and *D*](#F4){ref-type="fig"}). However, further expression analysis at the protein level revealed reduced levels of thermogenic proteins Ucp1, Dio2, and Cyt-c in *aP2-Id1^Tg+^* compared with *aP2-Id1^Tg−^* BAT ([Fig. 4*E*](#F4){ref-type="fig"}). Moreover, when mice were exposed to 4°C for 4 h, induction of thermogenic and mitochondrial genes was reduced in *aP2-Id1^Tg+^* compared with *aP2-Id1^Tg−^* BAT ([Fig. 4*F* and *G*](#F4){ref-type="fig"}). Consistent with reduced expression of thermogenic proteins, interscapular BAT harvested from *aP2-Id1^Tg+^* mice displayed reduced basal and uncoupled respiration compared with *aP2-Id1^Tg−^* BAT ([Fig. 4*H*](#F4){ref-type="fig"}). Because increased expression of Id1 suppressed the expression of thermogenic genes and reduced VO~2~, we asked whether loss of Id1 results in increased expression of thermogenic genes. To this end, we used *Id1^+/+^* and *Id1^−/−^* mice and detected a slight upregulation of *Ucp1* and a strong induction of *Elovl3* at RT in *Id1^−/−^* compared with *Id1^+/+^* BAT ([Fig. 4*I* and *J*](#F4){ref-type="fig"}). However, at the protein level, Ucp1 and Cyt-c were increased in *Id1^−/−^* compared with *Id1^+/+^* BAT ([Fig. 4*K*](#F4){ref-type="fig"}). In addition, exposure of mice to 4°C for 4 h led to a significant upregulation of thermogenic genes, such as *Ucp1*, *PPARγ*, *Cidea*, and *Dio2* in *Id1^−/−^* compared with *Id1^+/+^* BAT ([Fig. 4*L* and *M*](#F4){ref-type="fig"}). Moreover, interscapular BAT isolated from *Id1^−/−^* mice displayed increased basal and uncoupled respiration compared with *Id1^+/+^* BAT ([Fig. 4*N*](#F4){ref-type="fig"}). Together, these results indicate that Id1 suppresses thermogenic gene expression and lack of Id1 leads to increased expression of thermogenic genes.

![Thermogenic protein levels and VO~2~ rate are reduced in the BAT of *aP2-Id1^Tg+^* mice. *A*: Expression levels of Id1 and β-actin in the BAT of 2-month-old wild-type mice at RT and after exposing mice to 4°C for 4 h. *B*: Expression levels of Id1 and β-actin in the BAT of 2-month-old ND- or HFD-fed (1 week) wild-type mice. *C* and *D*: Relative mRNA transcript levels of thermogenic and mitochondrial genes in the BAT of *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice at RT. *E*: Expression levels of indicated proteins in the BAT of 2-month-old *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice at RT. *F* and *G*: Relative mRNA transcript levels of thermogenic and mitochondrial genes in the BAT of *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice after exposure to 4°C for 4 h. *H*: Basal respiration and uncoupled respiration (after blocking ATP synthase with oligomycin) were determined in the BAT explants of *aP2-Id1^Tg−^* and *aP2-Id1^Tg+^* male mice with an Oxygraph Plus System (*n* = 4). *I* and *J*: Relative mRNA transcript levels of thermogenic and mitochondrial genes in the BAT of *Id1^+/+^* and *Id1^−/−^* male mice at RT. *K*: Expression levels of indicated proteins in the BAT of 2-month-old *Id1^+/+^* and *Id1^−/−^* mice at RT. After acquiring images, band intensities were measured and normalized to β-actin by the Li-Cor Odyssey system. *L* and *M*: Relative mRNA transcript levels of thermogenic and mitochondrial genes in the BAT of *Id1^+/+^* and *Id1^−/−^* male mice after exposure to 4°C for 4 h (*n* = 6--8). *N*: Basal respiration and uncoupled respiration were determined in the BAT explants of *Id1^+/+^* and *Id1^−/−^* mice (*n* = 4). Data are mean ± SD. \**P* \< 0.05; \*\**P* \< 0.005.](db161079f4){#F4}

A number of factors activate or inhibit thermogenesis by either positively or negatively regulating the PGC1α/UCP1 thermogenesis pathway ([@B4],[@B6]--[@B8],[@B24]). Because Id1 lacks a DBD and regulates other transcription factors by direct interaction ([@B20],[@B25]), we reasoned that Id1 directly binds to a transcriptional activator of thermogenesis and suppresses its transcriptional activity. Alternatively, Id1 directly binds to a negative regulator of thermogenesis and promotes its inhibitory action, leading to reduced energy expenditure. To investigate these possibilities, we coexpressed Id1 and some of the known positive and negative regulators of thermogenesis in HEK293 cells and performed a series of coimmunoprecipitations (co-IPs). These analyses revealed a direct interaction between Id1 and PGC1α ([Fig. 5*A*](#F5){ref-type="fig"}), whereas Id1 did not interact with the other factors tested. Further analysis revealed a direct interaction between Id1 and PGC1α in day 6 differentiated HIB1B cells, indicating that Id1 indeed interacts with PGC1α endogenously ([Fig. 5*B*](#F5){ref-type="fig"}). In response to cold exposure, Id1 expression was induced ([Fig. 4*A*](#F4){ref-type="fig"}), and thermogenic gene expression was suppressed in *aP2-Id1^Tg+^* and increased in *Id1^−/−^* mouse BAT compared with controls ([Fig. 4*F* and *L*](#F4){ref-type="fig"}), Therefore, we asked whether a thermogenic stimulus promotes Id1 interaction with PGC1α to prevent excessive thermogenesis. We exposed wild-type mice to 4°C for 4 h and detected an increased interaction between Id1 and PGC1α in the BAT of mice exposed to 4°C compared with mice at RT ([Fig. 5*C*](#F5){ref-type="fig"}). To determine whether the Id1/PGC1α interaction affects PGC1α transcriptional activity, we performed a luciferase reporter assay in Cos7 cells by using a luciferase reporter driven by the Gal-upstream activation sequence (UAS) and full-length PGC1α fused with the DBD of yeast Gal4 as previously described ([@B26]). We found that the activity of Gal4-PGC1α was strongly inhibited when Id1 was coexpressed ([Fig. 5*D*](#F5){ref-type="fig"}). Moreover, coexpression of the *Ucp1* promoter--driven luciferase reporter vector along with *PPARγ*/*RXRα*/*PGC1α* or *PPARγ*/*RXRα*/*PGC1α*/*Id1* expression vectors revealed significant suppression of *Ucp1* promoter--driven luciferase activity when *Id1* was coexpressed ([Fig. 5*E*](#F5){ref-type="fig"}), suggesting that binding of Id1 indeed suppresses PGC1α transcriptional activity. Together, these results suggest that Id1 suppresses BAT thermogenesis by binding to and inhibiting the transcriptional activity of PGC1α.

![Id1 suppresses PGC1α transcriptional activity. *A*: Co-IP followed by Western blot showing a direct interaction between Id1 and PGC1α (HA tag), whereas Id1 did not directly interact with other proteins tested. Input: 2% of IP reaction. *B*: Co-IP followed by Western blot showing a direct interaction between endogenous Id1 and PGC1α in day 6 differentiated HIB1B cells. Input: 5% of IP reaction. *C*: Co-IP followed by Western blot showing a direct interaction between endogenous Id1 and PGC1α in the BAT of mice at RT and after exposure to 4°C for 4 h. Input: 5% of IP reaction. The higher-exposure image also was included to show PGC1α input bands not visible under lower exposure. Band intensities were measured and normalized to PGC1α input bands by the Li-Cor Odyssey system. *D*: Transcriptional activity of PGC1α was assayed by cotransfecting Cos-7 cells with luciferase reporter driven by Gal-UAS and Gal4-PGC1α plasmid (full-length PGC1α fused with the DBD of yeast Gal4) with various concentrations of the Id1 expression vector (*n* = 3). *E*: Transcriptional activity of PGC1α was assayed by cotransfecting Cos-7 cells with luciferase reporter driven by *Ucp1* promoter, PPARγ, RXRα (PPARγ binding partner), and various concentrations of Id1 plasmid (*n* = 2). Data are mean ± SD. \**P* \< 0.05; \*\**P* \< 0.005; \*\*\**P* \< 0.0005. IB, immunoblot.](db161079f5){#F5}

Id1 Deficiency Results in Increased Beige/Thermogenic Gene Expression in iWAT {#s12}
-----------------------------------------------------------------------------

In addition to BAT, Id1 was expressed in WAT ([Fig. 1*A*](#F1){ref-type="fig"}). WAT consists of adipocytes and the stromal vascular fraction (SVF) where the preadipocytes/progenitors reside ([@B27]). To investigate whether Id1 is expressed in the white adipocytes or in the SVF, we performed Id1 and CD45 (a general marker of SVF \[[@B28]\]) costaining on iWAT and detected a strong colocalization of Id1 and CD45 ([Fig. 6*A*](#F6){ref-type="fig"}), indicating that Id1 is mainly localized in the SVF of WAT and thus possibly involved in adipose progenitor cell differentiation. To investigate whether Id1 enhances or inhibits cold-induced brown-like (beige) differentiation of white preadipocytes in iWAT, we exposed *Id1^+/+^* and *Id1^−/−^* mice to 4°C for 12 h and analyzed the expression levels of the beige markers *Tbx1*, *Tmem26*, *CD40*, and *CD137* ([@B12]) and thermogenic genes in iWAT. We detected significant upregulation of *Tmem26*, *PPARγ*, *Ucp1*, and *Prdm16* in the iWAT of *Id1^−/−^* compared with *Id1^+/+^* mice ([Fig. 6*B* and *C*](#F6){ref-type="fig"}). Moreover, UCP1 staining on the iWAT of *Id1^+/+^* and *Id1^−/−^* mice after 12 h of cold exposure revealed strong UCP1 staining on *Id1^−/−^* iWAT and is not detectable on *Id1^+/+^* iWAT ([Fig. 6*D*](#F6){ref-type="fig"}). These observations suggest that loss of Id1 enhances browning of iWAT.

![Increased beige/thermogenic gene expression in the iWAT *Id1^−/−^* mice. *A*: Immunofluorescence staining showing the localization pattern of CD45 and Id1 in the iWAT of 2-month-old wild-type mice. iWAT sections incubated only with fluorescent secondary antibodies served as negative (--ve) controls. Scale bars = 100 μm. *B* and *C*: Relative mRNA transcript levels of beige and thermogenic genes in the iWAT of *Id1^+/+^* and *Id1^−/−^* male mice after exposure to 4°C for 12 h (*n* = 7). *D*: Representative immunohistochemistry staining showing the expression pattern of UCP1 in the iWAT of *Id1^+/+^* and *Id1^−/−^* mice after exposure to 4°C for 12 h (*n* = 5; 3 of 5 *Id1^−/−^* mice showed strong UCP1 staining in the iWAT; no staining was detected in the *Id1^+/+^* mice). Scale bar = 10 μm. iWAT sections incubated only with horseradish peroxidase--conjugated secondary antibody served as the --ve control. Data are mean ± SD. \**P* \< 0.05.](db161079f6){#F6}

Differentiation of Mouse Embryonic Fibroblasts Into Brown-Like Cells Is Increased in the Absence of Id1 {#s13}
-------------------------------------------------------------------------------------------------------

To further investigate whether loss of Id1 increases differentiation of white preadipocytes into brown-like cells, we harvested the SVF from *Id1^+/+^* and *Id1^−/−^* WAT and attempted to culture white adipose progenitors as previously described ([@B16],[@B29]). However, *Id1^−/−^* progenitor cells failed to grow and showed a senescence-like phenotype (data not shown), which is consistent with previous observations that Id1 promotes cell proliferation and lack of Id1 results in premature senescence in certain cell types ([@B30]). Therefore, we were unable to perform in vitro differentiation experiments in *Id1^−/−^* progenitor cells. To overcome this obstacle, we used an alternative in vitro system: early passage (P2) mouse embryonic fibroblasts (MEFs). MEFs are unprogrammed cells, share several characteristics with mesenchymal stem cells, and can differentiate into various mesenchymal lineages ([@B31]). MEFs can be induced to differentiate into brown-like cells that express mitochondrial and thermogenesis genes ([@B24],[@B32]). To test whether Id1 is involved in the differentiation of MEFs into brown-like cells, we treated *Id1^+/+^* and *Id1^−/−^* E13.5 MEFs with brown adipocyte differentiation media that consisted of rosiglitazone as previously described ([@B24]). We detected increased adipocyte differentiation in *Id1^−/−^* compared with *Id1^+/+^* cultures as revealed by enhanced expression of the adipocyte differentiation marker aP2 and Oil Red O staining ([Fig. 7*A* and *B*](#F7){ref-type="fig"}). Expression of Id1 is induced during differentiation of MEFs into brown adipocytes in *Id1^+/+^* cultures and is completely absent in *Id1^−/−^* cells as expected ([Fig. 7*A*](#F7){ref-type="fig"}). Consistent with increased brown adipogenesis, differentiated *Id1^−/−^* cells displayed increased mitochondrial content and increased cellular respiration compared with *Id1^+/+^* cells ([Fig. 7*C*--*E*](#F7){ref-type="fig"}). At the molecular level, *Id1^−/−^* cells displayed increased expression of beige and mitochondrial genes in day 10 differentiated cells, whereas their expression was similar in undifferentiated MEFs ([Fig. 7*F*--*I*](#F7){ref-type="fig"}). We also detected increased expression of thermogenic genes, such as *Pparγ*, *Pgc1α*, *Ucp1*, *Ebf2*, and *Prdm16*, in differentiated *Id1^−/−^* cells compared with *Id1^+/+^* cells ([Fig. 7*J* and *K*](#F7){ref-type="fig"}). Of note, the expression of *Ebf2* and *Prdm16*, the major determinants of brown adipocyte identity, were increased even in the nondifferentiated *Id1^−/−^* MEFs ([Fig. 7*J*](#F7){ref-type="fig"}). Further analysis at the protein level revealed elevated levels of aP2, PPARγ, PGC1α, Ebf2, and PRDM16 in *Id1^−/−^*-differentiating cells compared with *Id1^+/+^* cells ([Fig. 7*L*](#F7){ref-type="fig"}). We also analyzed RB and RIP140, which are known to suppress WAT browning ([@B33]). Although RB and pRB levels were unchanged, we found a detectable reduction in RIP140 levels in *Id1^−/−^* cells ([Fig. 7*L*](#F7){ref-type="fig"}). These results suggest that lack of Id1 promotes differentiation of MEFs into brown-like cells because of induced expression of PPARγ, Ebf2, PRDM16, and PGC1α.

![Increased beige/thermogenic gene expression in *Id1^−/−^* MEFs. *A*: Representative Oil Red O staining of day 10 differentiated *Id1^+/+^* and *Id1^−/−^* MEFs. Scale bar = 20 μm. *B*: Expression patterns of Id1, aP2, and β-actin in differentiating MEFs at the indicated time points after inducing brown adipogenesis. *C* and *D*: FACS analysis of unstained and nonyl acridine orange--stained day 10 differentiated *Id1^+/+^* and *Id1^−/−^* MEFs (*C*) and the quantification of fluorescence level (FL) (*D*) (*n* = 4). *E*: Basal and uncoupled respiration (after blocking ATP synthase with oligomycin) rate of day 10 differentiated *Id1^+/+^* and *Id1^−/−^* MEFs (*n* = 3). *F*--*K*: Relative mRNA transcript levels of beige (*F* and *G*), mitochondrial (*H* and *I*), and thermogenic (*J* and *K*) genes in nondifferentiated (ND) (*F*, *H*, and *J*) and day 10 differentiated (D10) (*G*, *I*, and *K*) *Id1^+/+^* and *Id1^−/−^* MEFs (*n* = 3). *L*: Expression levels of indicated proteins in *Id1^+/+^* and *Id1^−/−^* differentiating MEFs at the indicated time points after inducing brown adipogenesis. Data are mean ± SD. \**P* \< 0.05; \*\**P* \< 0.005; \*\*\**P* \< 0.0005.](db161079f7){#F7}

Id1 Directly Binds to and Suppresses Ebf2 Transcriptional Activity {#s14}
------------------------------------------------------------------

Previously, it was demonstrated that by recruiting PPARγ to the *Prdm16* promoter, Ebf2 induces the expression of *Prdm16*, which determines brown adipocyte cell fate ([@B14]--[@B16],[@B34]). Ebf2 is a helix-loop-helix transcription factor, and Id proteins are known to interact with helix-loop-helix proteins with very high affinity ([@B20],[@B25]), indicating the possibility of a direct interaction between Id1 and Ebf2. Therefore, we asked whether Id1 downregulates *Prdm16* expression by directly interacting with and suppressing Ebf2 transcriptional activity. To this end, we first asked whether Id1 and Ebf2 colocalize in WAT. We stained for Id1 and Ebf2 on iWAT and detected colocalization of Id1 and Ebf2 ([Fig. 8*A*--*C*](#F8){ref-type="fig"}), indicating the possibility of a direct interaction between Id1 and Ebf2. Next, we coexpressed Id1 and Ebf2 in HEK293 cells and performed co-IP, which revealed a direct interaction between Id1 and Ebf2 ([Fig. 8*D*](#F8){ref-type="fig"}). To determine whether Id1 binding to Ebf2 affects the transcriptional activity of Ebf2, we coexpressed a *Prdm16* promoter--driven luciferase reporter vector along with *PPARγ/RXRα/Ebf2* or *PPARγ/RXRα/Ebf2/Id1* expression vectors. We detected a significant suppression of *Prdm16* promoter--driven luciferase activity when *Id1* is coexpressed with *PPARγ/RXRα/Ebf2* ([Fig. 8*E*](#F8){ref-type="fig"}), whereas in the absence of Ebf2, Id1 did not suppress *Prdm16* promoter--driven luciferase activity ([Fig. 8*F*](#F8){ref-type="fig"}), suggesting that Id1 downregulates *Prdm16* expression by binding to and suppressing the transcriptional activity of Ebf2. Because Id1 does not have a DBD and directly binds to Ebf2 and PGC1α, we wondered whether Id1 colocalizes with Ebf2 and PGC1α on their regulatory regions, such as the *Prdm16* and *Ucp1* promoters. Chromatin IP-qPCR assays in day 4 differentiated HIB1B cells revealed that Id1 is localized to the *Prdm16* promoter region but not to the *Ucp1* promoter region ([Fig. 8*G* and *H*](#F8){ref-type="fig"}). These observations indicate that Id1 can associate with Ebf2 at the Ebf2 regulatory regions, whereas Id1/PGC1α interaction precludes PGC1α from associating with its regulatory regions. As a result, Id1 is not associated with the *Ucp1* promoter.

![Id1 suppresses Ebf2 transcriptional activity. *A*--*C*: Immunofluorescence staining showing the localization patterns of CD45/Ebf2 and Id1/Ebf2 in the iWAT of 2-month-old wild-type mice. Scale bars = 100 μm (*A* and *B*) and 20 μm (*C*). *D*: Co-IP followed by Western blot showing a direct interaction between Id1 and Ebf2. Input: 2% of IP reaction. *E*: Relative reporter activity of *Prdm16* promoter--driven luciferase activity in the presence of PPARγ, RXRα (PPARγ binding partner), Ebf2, and different concentrations of Id1 plasmid (*n* = 2). *F*: Relative reporter activity of *Prdm16* promoter--driven luciferase activity in the presence of PPARγ and RXRα and in the presence and absence of Ebf2 and Id1 (*n* = 2). Id1 suppressed *Prdm16* promoter--driven luciferase activity only when Ebf2 was present. *G* and *H*: Chromatin IP-qPCR analysis of Ebf2 and Id1 binding to the *Prdm16* promoter (*G*) and PGC1α and Id1 binding to the *Ucp1* promoter (*H*) in day 4 differentiated HIB1B cells after normalizing to 18S DNA binding (*n* = 2). Data are mean ± SD. \**P* \< 0.05; \*\**P* \< 0.005; \*\*\**P* \< 0.0005. IB, immunoblot; kb, kilobase; n.s, not significant.](db161079f8){#F8}

Discussion {#s15}
==========

Id1 has been known to play critical roles in cell proliferation, cellular differentiation, and tumorigenesis ([@B35],[@B36]). Previously, we and others demonstrated that Id1 whole-body knockout mice (*Id1^−/−^*) are lean and protected from HFD-induced insulin resistance and hepatosteatosis ([@B37],[@B38]). However, the adipose tissue--specific function of Id1 and its relative contribution to body energy expenditure remains unclear because it is a whole-body *Id1*-deficient mouse. In the current work, we discovered a novel function of Id1 in BAT-mediated thermogenesis and its potential involvement in the programming of preadipocytes into brown-like adipocytes. During HIB1B brown adipocyte differentiation, the Id1 expression pattern closely mimicked the expression pattern of PPARγ, PGC1α, and UCP1. However, unlike PPARγ, which is absolutely required for both white and brown adipocyte differentiation ([@B39]), Id1 is dispensable for brown adipocyte differentiation. Previously, it was demonstrated that Id1 is not required for white adipocyte differentiation ([@B37]), indicating that Id1 is dispensable for both white and brown adipocyte differentiation. The *aP2-Id1^Tg+^* mice displayed reduced energy expenditure, indicating that Id1 suppresses BAT thermogenesis. In *aP2-Id1^Tg^* BAT, thermogenic gene expression is mildly reduced compared with controls at RT, but over time, this can have a significant effect on body weight because it slowly but steadily reduces body energy expenditure. For this possible reason, *aP2-Id1^Tg^* mice gained weight slowly during aging. Id1 lacks a DBD; therefore, the only way Id1 could inhibit thermogenesis is by directly binding to and suppressing the transcriptional activity of a factor that promotes thermogenesis. Our attempt to identify a possible interaction between Id1 and some of the known activators/suppressors of thermogenesis unexpectedly revealed a direct interaction between Id1 and PGC1α with a concomitant suppression of PGC1α transcriptional activity. If Id1 suppresses PGC1α transcriptional activity, then why is the PGC1α downstream target UCP1 only slightly reduced when Id1 levels are strongly increased during HIB1B differentiation? A possible explanation could be that PPARγ, PGC1α, and UCP1 are highly expressed in fully differentiated HIB1B cells and in the BAT where the majority of the cells are mature, fully differentiated brown adipocytes. The transcription factors Twist-1 and Cidea, which inhibit PGC1α and UCP1, also are highly expressed in BAT ([@B26],[@B40]). Therefore, both the activators and the suppressors of thermogenesis appear to coexist in the BAT and in fully differentiated brown adipocytes. When thermogenesis is strongly activated, it triggers a negative feedback loop that further induces the expression of the thermogenic suppressors such as Id1, which in turn prevents excessive thermogenesis by inhibiting PGC1α and/or UCP1. Consistent with this explanation, we found that cold exposure enhanced the expression of Id1, which in turn resulted in increased interaction between Id1 and PGC1α. Conversely, cold exposure results in increased expression of UCP1 in the BAT of *Id1^−/−^* mice ([@B37]).

In the adipose progenitor cells, Ebf2 and PPARγ cooperatively induce the expression of *Prdm16*, which controls beige adipocyte determination. We found that both Id1 and Ebf2 are mainly localized in the SVF of iWAT, where the adipose progenitors reside. Furthermore, Id1 directly interacted with Ebf2 and suppressed its transcriptional activity, leading to impaired expression of *Prdm16*. Consequently, in *Id1^−/−^* iWAT, the expression of beige and thermogenic genes, including *Prdm16*, was increased in response to prolonged cold exposure. In addition, the differentiation of MEFs into brown-like cells is significantly increased in the absence of Id1, which contrasts with our observation that Id1 is dispensable for HIB1B brown adipocyte differentiation. A possible reason for the knockdown or overexpression of Id1 not affecting differentiation of HIB1B cells could be that HIB1B cells comprise a preprogrammed brown adipocyte cell line, and upon brown adipogenic stimulation, they differentiate into brown adipocytes. Therefore, HIB1B cell differentiation may no longer be influenced by the factors involved in the earlier cell fate determination. Id1 appears to participate in the earlier programming of preadipocytes into beige adipocytes by regulating Ebf2 transcriptional activity. Ebf2 determines not only beige but also brown adipocyte cell fate, and loss of *Ebf2* results in a significant reduction of BAT and an almost total loss of brown fat--specific gene expression in *Ebf2^−/−^* embryos ([@B16]). If Id1 functions as an upstream inhibitor of Ebf2, then why does elevated expression of Id1 (*aP2-Id1^Tg+^*) or loss of Id1 (*Id1^−/−^*) have no detectable effect on BAT development? A possible explanation is that in *aP2-Id1^Tg+^* mice, Id1 expression is directed by the aP2 promoter/enhancer, which may not be active in the adipose progenitors during embryonic development. Therefore, Id1 may not have been induced during brown adipocyte cell fate determination in *aP2-Id1^Tg+^* mice and therefore did not interfere with Ebf2/Prdm16-mediated brown adipocyte programming and BAT development. In *Id1^−/−^* mice, Ebf2 is free from Id1-mediated suppression and induces *Prdm16* expression, leading to normal BAT development. In contrast to brown adipocytes, beige adipocytes are generated in response to a substantial physiological stimulus, such as prolonged cold exposure or β3-androgen receptor-adrenergic agonists ([@B12],[@B41],[@B42]). Of note, Id1 expression is also strongly induced in response to cold exposure. Once induced, Id1 functions as an upstream transcriptional suppressor of Ebf2, and in the absence of Id1, Ebf2-mediated browning of iWAT is enhanced. Together, the current results suggest that Id1 regulates two pathways---PGC1α/Ucp1 thermogenic and Ebf2/Prdm16 adipose progenitor cell programming---by inhibiting PGC1α in the BAT and Ebf2 in the progenitor cells. Nevertheless, we cannot exclude the possibility that Id1 also interacts with PGC1α in the progenitor cells. However, Id1/PGC1α interaction may not prevent the progenitors from differentiating into brown-like cells because neither PGC1α nor Id1 is required for brown adipocyte differentiation.

In contrast to males, female *aP2-Id1^Tg+^* mice are protected from age- and HFD-associated obesity. Sex-dependent differences in energy intake, storage, and expenditure are well known, and these physiological mechanisms are under the control of sex hormones ([@B43]). For example, ovarian estrogens control energy homeostasis ([@B44]), and estradiol activates thermogenesis in BAT through the sympathetic nervous system ([@B45]). In the current study, Id1-mediated suppression of energy expenditure caused obesity in males but not in females, suggesting that female sex hormones can counteract the effects of some of the negative regulators of energy expenditure. Therefore, future studies should focus on exploring which of these factors are under the control of female sex hormones. In the current study, we used *aP2-Id1^Tg^* mice, and other studies demonstrated that *aP2* promoter--driven expression is not highly specific to adipose tissues and can have certain low, nonspecific expression in other tissues, such as the lung, heart, muscle, liver, and testes ([@B46]--[@B48]). In the current *aP2-Id1^Tg^* mouse model, we did not detect any difference in lean mass and bone density between control and *aP2-Id1^Tg+^* mice. Moreover, female *aP2-Id1^Tg+^* mice did not show detectable phenotypes in adipose or other tissues, suggesting that *aP2* promoter--driven Id1 expression did not cause significant side effects.

In conclusion, this study demonstrates that by suppressing PGC1α-mediated BAT thermogenesis and Ebf2-mediated beige adipocyte programming, Id1 promotes energy storage and obesity, which is a significant risk factor for insulin resistance and diabetes. Therefore, Id1 could potentially function as a molecular target to reverse obesity. *Id1^−/−^* mice are viable and fertile and live normally, suggesting that most cell types do not require Id1 for normal functioning. Therefore, targeting Id1 in vivo could be a relatively safe strategy to increase energy expenditure, reduce adiposity, and treat obesity and its associated diseases, such as diabetes.
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